Evista (chemical name: raloxifene) is a SERM approved by the U.S. Food and Drug Administration (FDA) to: 1  reduce the risk of hormone-receptor-positive breast cancer in postmenopausal women who haven't been diagnosed but are at higher-than-average risk for disease.
Types of paper ICT Express publishes original research papers in English in the fields of ICT convergence, platform technologies, communication networks, and device technologies. ICT Express accepts short-length (up to 4 pages in double columns and additional 2 pages will be allowed with over page charge (100USD/1page)) high-quality, original articles in Latex or Word format. Sample manuscript can be downloaded here.
A post-event wrap up report is most useful within days of the event, and itâs best if you can publish your piece within 48 hours of the eventâs conclusion. A wrap up report should be published no more than two weeks after the event. At two weeks out, the news is a bit stale so do your best to aim for 48 hours after the event, with a week or less time being OK but not optimal.